In addition, this biomarker, which is based on the detection of specific PSA glycoforms, significantly correlated with the Gleason score of the tumor (correlation coefficient 0.554, p < 0.001) (Figure 1D), which highlights its potential as a marker for aggressive PCa. The gene discussed is KLK3; the disease is posterior cortical atrophy.